advertisement

WGA Rescources

Shi J 9

Showing records 1 to 9 | Display all abstracts from Shi J

104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Yang Y
BMC Ophthalmology 2022; 22: 249
104571 Effects of Recombinant Human Epidermal Growth Factor Eye Drops Combined with Phacoemulsification on Short- and Long-Term Visual Acuity Recovery and Related Dry Eye Complications in Patients with Senile Cataract
Fan L
Computational and mathematical methods in medicine 2022; 2022: 1041558
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Huang X
BMC Ophthalmology 2022; 22: 249
104571 Effects of Recombinant Human Epidermal Growth Factor Eye Drops Combined with Phacoemulsification on Short- and Long-Term Visual Acuity Recovery and Related Dry Eye Complications in Patients with Senile Cataract
He T
Computational and mathematical methods in medicine 2022; 2022: 1041558
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Liao S
BMC Ophthalmology 2022; 22: 249
104571 Effects of Recombinant Human Epidermal Growth Factor Eye Drops Combined with Phacoemulsification on Short- and Long-Term Visual Acuity Recovery and Related Dry Eye Complications in Patients with Senile Cataract
Shi J
Computational and mathematical methods in medicine 2022; 2022: 1041558
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Zhang F
BMC Ophthalmology 2022; 22: 249
104571 Effects of Recombinant Human Epidermal Growth Factor Eye Drops Combined with Phacoemulsification on Short- and Long-Term Visual Acuity Recovery and Related Dry Eye Complications in Patients with Senile Cataract
Ke X; Lu X
Computational and mathematical methods in medicine 2022; 2022: 1041558
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Shi J; Duan X; Liu K
BMC Ophthalmology 2022; 22: 249

Issue 23-2

Change Issue


advertisement

Topcon